FROM OUR BLOG

Radial Buys TMS Health Partners; US Debt & Oil Markets

Radial acquires TMS Health Partners' MSO assets; Cityblock buys Homeward Health; plus Treasury buybacks, oil prices, and India's hawkish RBI move.

August 20, 2026

Healthcare Practice & Business Deals

2017.01.13 WELL MindShift at Center for Total Health 02521
Photo: tedeytan — BY-SA 2.0

Two notable small-to-medium healthcare deals highlight this week’s activity, with interventional psychiatry and rural primary care both attracting strategic buyers.

Radial acquires TMS Health Partners MSO. Radial has agreed to acquire the non-clinical assets of TMS Health Partners, the management services organization supporting a network of 20 brain medicine clinics specializing in interventional psychiatry. The clinics offer treatments including Spravato and transcranial magnetic stimulation (TMS). Financial terms were not disclosed. The deal gives Radial a significant platform in a fast-growing subspecialty that sits at the intersection of mental health access and advanced neuromodulation therapies — precisely the kind of MSO roll-up that private-equity-backed acquirers have been targeting as behavioral health consolidation accelerates.

Cityblock Health acquires Homeward Health, raises $116M. Cityblock Health has inked a deal to acquire Homeward Health, a move designed to extend Cityblock’s community-based care model into rural markets. Simultaneously, Cityblock closed a $116 million funding round. Combined, the two companies will serve nearly 250,000 people, with ambitions to reach the estimated 120 million Americans enrolled in government-funded healthcare programs. The acquisition pairs Cityblock’s urban, Medicaid-focused infrastructure with Homeward’s rural reach — a combination that positions the merged entity to compete for value-based government contracts at meaningful scale.

Global Markets & Macro

Landscape
Photo: Raffaele De Grada — BY-SA 3.0

Markets are navigating a convergence of US fiscal pressure, rising commodity prices, and central bank signals that continue to test investor confidence across asset classes.

US debt burden moves to center stage. America’s national debt — with roughly $32 trillion held by the public — is drawing renewed scrutiny after the Conference Board warned that growing deficits put upward pressure on interest rates and borrowing costs for households and businesses. The federal government is projected to spend more than $1 trillion on net interest payments in 2026, exceeding spending on every mandatory program except Social Security and Medicare, according to the Congressional Budget Office. The concern: if investors begin to view US debt as riskier, mortgage rates, auto loans, and small-business credit could all tighten further.

Treasury buybacks stir bond markets — but questions remain. US Treasury Secretary Scott Bessent has made a high-stakes bet that buying back long-dated bonds can suppress long-term borrowing costs. Markets responded with volatility: a Treasury buyback session sent quant funds reeling as momentum trades in Treasuries and equities were caught off-guard. The Financial Times noted the buyback program remains small in scale relative to the size of the $32 trillion market, raising doubts about its lasting impact on yields. Asian bonds followed Treasuries lower, and the dollar remained under pressure as investors reassessed whether the strategy offers more than a temporary reprieve.

Oil heads for a strong weekly gain on Iran tensions. Crude oil is on track for a substantial weekly advance after a US push to tighten economic pressure on Iran raised fears of further supply disruption. The prospect of reduced Iranian oil exports is lending support to prices at a time when global demand signals remain mixed. Energy markets are watching closely for any escalation that could accelerate the supply shock.

India’s RBI surprises bond traders with hawkish tone. Minutes from the Reserve Bank of India’s latest meeting struck a more hawkish note than traders had anticipated, sending Indian bond yields higher. As inflows from the RBI’s foreign-currency deposit scheme begin to fade, analysts warn that yields could drift higher still. Separately, India’s securities regulator issued a swift interim order against a JPMorgan unit, which market watchers interpreted as a firm warning against attempts to manipulate the country’s new closing stock auction mechanism — reinforcing that Indian regulators are prepared to move fast against major institutions.

Nvidia and AI infrastructure remain market focal points. Nvidia continues to attract attention as analysts assess its positioning for the next phase of AI infrastructure buildout, with the Financial Times noting the company is using its balance sheet to seed new markets and business models. Meanwhile, public sentiment toward data centers — the physical backbone of AI — is becoming politically charged, with a recent survey showing 70% of Americans opposing data center construction in their communities, a dynamic that could complicate Big Tech’s capital deployment plans.

What to Watch

For healthcare deal-watchers, Radial’s TMS Health Partners acquisition signals that interventional psychiatry MSOs are firmly in buyers’ crosshairs — expect more behavioral health roll-ups as the year closes. On the macro side, the interplay between Treasury buyback credibility, long-term yield direction, and the swelling US debt load will define the cost of capital for small-business borrowers and practice buyers alike; any upward drift in the 10-year Treasury yield feeds directly into the financing costs that drive healthcare M&A valuations. Watch the Federal Reserve’s next communications carefully, as the RBI’s hawkish pivot and persistent US fiscal pressures together suggest the global rate environment may stay higher for longer than markets priced just weeks ago.


Editorial note, image use & corrections. This report is compiled and summarized from publicly available news sources; figures and details should be independently verified. Accompanying images are used under Creative Commons or public-domain licenses (sourced via Openverse) and credited where required. If you believe any content — written or image — has been used in error, is inaccurate, or infringes your rights, or you wish to request a correction or removal, please contact us at info@tenetma.com and we will address it promptly.

THINKING ABOUT SELLING YOUR MEDICAL PRACTICE?

Get a confidential practice valuation.

If you’re considering selling your practice — or exploring your options — a confidential valuation is a helpful first step. Understanding market conditions and potential value provides clarity and supports better decisions around timing and strategy.

START THE CONVERSATION

If you’re considering a sale, exploring acquisitions or planning ahead,
we’re here to help.

Schedule a confidential consultation to learn how our services can support your goals.